Results 101 to 110 of about 5,546 (214)

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial [PDF]

, 2017
Matthew H. Kulke, Philippe Ruszniewski, Eric Van Cutsem, Catherine Lombard‐Bohas, Juan W. Valle, Wouter W. de Herder, Marianne Pavel, Evgeny Degtyarev, Jan C. Brase, Lida Bubuteishvili‐Pacaud, Maurizio Voi, Ramón Salazar, Ivan Borbath, Nicola Fazio, Denis Smith, Jaume Capdevila, Rachel P. Riechelmann, Jin‐Guang Yao   +17 more
openalex   +1 more source

Abstracts

Molecular Oncology, Volume 19, Issue S1, Page 1-940, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide

Medicina
Background and Objectives: High-grade malignant neuroendocrine tumors (G3 NETs) and neuroendocrine carcinomas (NECs) are characterized by rapid proliferation, high metastatic capacity, and strong expression of somatostatin receptors (SSTRs).
Kevin Doello, Maria Angeles Chico, Francisco Quiñonero, Raúl Ortiz, Jose Prados, Cristina Mesas, Consolación Melguizo   +6 more
doaj   +1 more source

Somatostatin Receptor Scintigraphy in Medullary Thyroid Cancer [PDF]

, 2015
Medullary thyroid cancer (MTC) is a neuroendocrine tumor originating from the calcitonin‐secreting C cells. Surgery, consisting of a total thyroidectomy and an extensive lymph node dissection, is the only effective treatment in MTC; however, metastases ...
Brouwers, Adrienne, Links, Thera, van der Horst-Schrivers, Anouk N. A.   +2 more
core   +1 more source

Serum N-Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism [PDF]

, 2016
BACKGROUND: N‐terminal type III procollagen propeptide (PIIINP) is a biomarker of soft tissue proliferation. Hypersomatotropism (HS) is associated with soft tissue proliferation.
Church, D B, Forcada, Y, Kenny, P J, Keyte, S V, Niessen, S J M   +4 more
core   +3 more sources

Pasireotide for uncontrolled acromegaly—new phase III trial data [PDF]

, 2014
Jennifer Sargent
openalex   +1 more source

Pasireotide in Acromegaly: An Overview of Current Mechanistic and Clinical Data [PDF]

, 2015
Susan L. Samson
openalex   +1 more source

Impact of pasireotide on postoperative pancreatic fistulas following distal resections [PDF]

, 2021
Tiina Vuorela, Harri Mustonen, Arto Kokkola, Caj Haglund, Hanna Seppänen   +4 more
openalex   +1 more source

Pasireotide [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1–Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression [PDF]

, 2016
Gerard Walls, Mark Stevenson, B Soukup, Kate E Lines, Ashley Grossman, Herbert Schmid, Rajesh V. Thakker   +6 more
openalex   +1 more source